Lipid droplets (LDs) are recently recognized dynamic organelles present in most eukaryotic cells. For a long time, they were considered to be inert lipid storage sites, but studies have shown that they are important regulators of lipid metabolism, which control the uptake of fatty acids from the environment, their distribution, storage and use for various purposes within the cell. Moreover, they act as important modulators of the cellular response to stress, being involved in maintaining energy and redox homeostasis, membrane and organelle integrity, and in the cellular protection against lipototoxicity. The ability of cancer cells to survive stressful conditions, such as the lack of oxygen and nutrients, is crucial for tumor growth and a vulnerability that may be exploited for therapeutic purposes. One of the key characteristics that enable cancer cell survival during stress is the biogenesis of LDs, but the causes and mechanisms of LD formation and breakdown under different growth conditions have not yet been fully elucidated. The major goal of this work was to examine the impact of changes in LD dynamics on the growth and proliferation of MDA-MB-231 breast cancer cells. We hypothesized that LD turnover and cell growth would be affected either by inhibition of diacylglycerol acyltransferases (DGATs) 1 and 2 that catalyze triglyceride synthesis, which is a prerequisite for LD formation, or by overexpression of adipose triglyceride lipase (ATGL), which is crucial for triglyceride lipolysis and LD degradation. We found that the inhibition of DGAT1 and DGAT2 enzymes significantly reduced the number of LDs in breast cancer cells. We also found that inhibition of DGAT1, but not DGAT2, slows the proliferation of breast cancer cells and reduces their ability to form independent colonies. On the other hand, our data show that ectopic overexpression of ATGL does not have a significant effect on neutral lipid content in breast cancer cells, but stimulates their proliferation. Our results therefore suggest that triglyceride synthesis and lipolysis are important for the growth and division of breast cancer cells. Targeting the major LD metabolism enzymes DGAT and ATGL is therefore of interest for further studies towards the discovery of new therapeutic approaches in cancer.
|